☆ 4.5 Article

Systematic pan-cancer analysis identifies transmembrane protein 158 as a potential therapeutic, prognostic and immunological biomarker

FUNCTIONAL & INTEGRATIVE GENOMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biotechnology & Applied Microbiology

TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas

Jiabo Li et al.

Summary: The study found that TMEM158 is highly expressed in gliomas and is associated with tumor malignancy and patient survival. Silencing TMEM158 inhibits the proliferation of glioma cells, while overexpression of TMEM158 promotes the migration and invasion of glioma cells.

CANCER GENE THERAPY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Discovering dominant tumor immune archetypes in a pan-cancer census

Alexis J. Combes et al.

Summary: This study identifies common patterns of the immune system in different types of cancer and proposes strategies to modulate tumor immunity for improved therapy. The findings provide new insights into cancer immunity and offer a rational approach to enhance treatment.

CELL (2022)

添加到收藏夹

Article Oncology

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

M. Palmeri et al.

Summary: This real-world study reinforces the use of TMB as a predictive biomarker, and suggests that clinicians should consider treating TMB-H patients with immunotherapy.

ESMO OPEN (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Targeted therapies for cancer

Zhijun Zhou et al.

Summary: Targeted therapy is crucial for improving overall survival and reducing side effects in cancer treatment, but each patient responds differently to treatment. The development of cutting-edge technologies, such as next-generation sequencing, has allowed for the identification of more actionable targets. This special issue of BMC Medicine presents a collection of studies on targeted therapies for various cancer types, aiming to bridge the gap between genomic testing and precision medicine and spark innovations in improving the efficacy of targeted therapies.

BMC MEDICINE (2022)

添加到收藏夹

Review Oncology

The translational challenges of precision oncology

Oriol Pich et al.

Summary: The translational challenges in the field of precision oncology are partly due to the complexity and diversity of cancer. Advances in genomics have enabled large-scale sequencing efforts and discoveries, impacting our understanding of cancer initiation, prevention, treatment, and other concepts. Key areas for improving cancer outcomes are discussed, along with the practical challenges of adopting molecular profiling in clinical settings and the need for robust translational infrastructure.

CANCER CELL (2022)

添加到收藏夹

Article Oncology

Pan-cancer analysis of prognostic metastatic phenotypes

Nicholas G. Zaorsky et al.

Summary: This project aimed to redefine staging of metastatic cancer, identified five metastatic phenotypes through latent class analysis, and found long-term survivors. All metastatic cancer is considered as Stage IV disease.

INTERNATIONAL JOURNAL OF CANCER (2022)

添加到收藏夹

Article Cell Biology

Multiple roles for basement membrane proteins in cancer progression and EMT

Samarpita Banerjee et al.

Summary: Metastasis is a major challenge in cancer therapy, and the epithelial-mesenchymal transition plays a critical role in this process. Collagen, laminin, and integrin are important components involved in tumor cell metastasis and can also serve as biomarkers for metastatic cells. This review summarizes the current knowledge of therapeutics in preclinical or clinical stages.

EUROPEAN JOURNAL OF CELL BIOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics

Yoshikatsu Kanai

Summary: Cancer cells require a massive supply of nutrients, including amino acids. LAT1 is an amino acid transporter that is specifically expressed in cancer cells. High expression of LAT1 is associated with poor prognosis in patients. Inhibition of LAT1 can suppress cancer cell proliferation and tumor growth. LAT1 can also be used as a target for cancer diagnosis and specific delivery of anti-tumor drugs.

PHARMACOLOGY & THERAPEUTICS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function

Gokcen Eraslan et al.

Summary: Understanding the function and regulation of genes in homeostasis and disease requires knowledge of their expression in different cellular and tissue contexts. In this study, we performed single-nucleus RNA sequencing on various frozen tissue types, generating a cross-tissue atlas of cellular profiles. By integrating this atlas, we identified shared and tissue-specific features of cell populations, as well as cell types and gene modules associated with neuromuscular, metabolic, and immune components of monogenic diseases and complex traits analyzed by genome-wide association studies.

SCIENCE (2022)

添加到收藏夹

Article Oncology

Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: A correlation meta-analysis

Jaffer A. Ajani et al.

Summary: Based on a meta-analysis of trials for resectable esophageal or gastroesophageal junction cancer, disease-free survival (DFS) was found to be a valid surrogate endpoint for overall survival (OS) in different treatment settings.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Genetics & Heredity

A transmembrane protein family gene signature for overall survival prediction in osteosarcoma

Yuehui Du et al.

Summary: We constructed a prognostic signature based on six TMEM protein family genes and found that it can stratify osteosarcoma patients into high- and low-risk groups. Functional enrichment analysis revealed the association between immunity and the prognostic signature. Additionally, the high-risk group had lower proportions of M2 macrophages in the immune microenvironment and lower scores of neutrophils and Treg.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer

Yingkun Xu et al.

Summary: CDCA3 is an essential regulator in cell mitosis and its dysregulation is common in human cancers. Our comprehensive analysis using multiple cancer-related databases and bioinformatics tools revealed that CDCA3 is overexpressed in almost all cancer types and is significantly associated with survival in multiple cancer types. CDCA3 expression positively correlates with immune cell infiltration levels in human cancers. Moreover, overexpression of CDCA3 may promote the malignant progression of cancer by activating various oncogenic signaling pathways.

BIOMED RESEARCH INTERNATIONAL (2022)

添加到收藏夹

Article Oncology

TMEM158 Regulates the Canonical and Non-Canonical Pathways of TGF-? to Mediate EMT in Triple-Negative Breast Cancer

Jiaci Tong et al.

Summary: This study evaluated the expression and prognostic relevance of TMEM158 in breast cancer patients and found that TMEM158 is closely associated with epithelial-mesenchymal transition (EMT) and TGF-8 pathways. Functional experiments demonstrated that overexpressed TMEM158 may participate in tumor migration, invasion, and metastasis by activating the TGF-8 pathway.

JOURNAL OF CANCER (2022)

添加到收藏夹

Review Physiology

DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS

Giulia Biffi et al.

Summary: Efforts to develop anti-cancer therapies have mainly targeted the epithelial compartment, but recent studies have shown the significant influence of cancer-associated fibroblasts (CAFs) in tumor progression. CAFs not only promote cancer cell proliferation, therapy resistance, and immune exclusion, but may also restrain tumor progression in certain contexts. Research on CAFs has focused on their heterogeneity, plasticity, and functions across different cancer types and states, as well as advancements in therapeutic strategies targeting CAFs currently undergoing preclinical and clinical evaluation.

PHYSIOLOGICAL REVIEWS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Review Oncology

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker

Denis L. Jardim et al.

Summary: Tumor mutational burden (TMB) reflects cancer mutation quantity and correlates with better outcomes of immune checkpoint inhibitors (ICIs). However, TMB as a biomarker is imperfect and a composite predictor including critical variables is needed.

CANCER CELL (2021)

添加到收藏夹

Review Immunology

Tumor Mutational Burden Predicting the Efficacy of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review and Meta-Analysis

Yan Li et al.

Summary: This meta-analysis demonstrated that colorectal cancer patients with high TMB had longer overall survival and higher objective response rates when receiving ICIs, suggesting that TMB can be used as a potential predictive biomarker for the efficacy of immunotherapy in this patient population. Further randomized controlled trials are needed to confirm the reliability of TMB as a predictive biomarker and to determine the most relevant biomarker when TMB high overlaps with other biomarkers like MSI and TILs.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Oncology

Clinical and therapeutic relevance of cancer-associated fibroblasts

Yang Chen et al.

Summary: CAFs, as highly versatile and resilient cells in primary and metastatic tumors, play crucial roles in cancer progression through complex interactions with other cell types in the tumor microenvironment. Their heterogeneity and dynamic interactions are key factors in cancer development.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

添加到收藏夹

Review Oncology

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer Patients

Ye Wang et al.

Summary: The response to immune checkpoint inhibitors is a complex quantitative trait determined by multiple factors, for which FDA-approved biomarkers are used for patient selection. However, challenges in daily practice and the different factors captured by the biomarkers highlight the need for optimized use of current biomarkers and development of new predictive biomarkers. Various gene signature biomarkers and combined predictive biomarkers have shown improved performance compared to single predictors, suggesting a potential direction for robust predictive biomarker development for ICI response.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer

Fanglong Wu et al.

Summary: CAFs play vital roles in cancer progression and their complex signaling pathways with cancer cells are crucial for understanding the development of cancer.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Oncology

Current and future cancer staging after neoadjuvant treatment for solid tumors

David R. Byrd et al.

Summary: It is important to distinguish between clinical and pathological assessments with or without NAT to avoid misunderstanding. Collecting data after NAT at cancer registries is crucial for evaluating the treatment effectiveness.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway

Yue Fu et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

添加到收藏夹

Review Oncology

Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process

Marx Sebastien et al.

SEMINARS IN CANCER BIOLOGY (2020)

添加到收藏夹

Review Oncology

The life cycle of cancer-associated fibroblasts within the tumour stroma and its importance in disease outcome

Elisa D'Arcangelo et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Origin and functional heterogeneity of fibroblasts

Valerie S. LeBleu et al.

FASEB JOURNAL (2020)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

SnapShot: Cancer-Associated Fibroblasts

Danielle Park et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

TIMER2.0 for analysis of tumor-infiltrating immune cells

Taiwen Li et al.

NUCLEIC ACIDS RESEARCH (2020)

添加到收藏夹

Review Toxicology

Microsatellite instability in cancer: a novel landscape for diagnostic and therapeutic approach

Hiroyuki Yamamoto et al.

ARCHIVES OF TOXICOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

The tumor microenvironment

Nicole M. Anderson et al.

CURRENT BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cell type-specific genetic regulation of gene expression across human tissues

Sarah Kim-Hellmuth et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

The GTEx Consortium atlas of genetic regulatory effects across human tissues

Francois Aguet et al.

SCIENCE (2020)

添加到收藏夹

Review Cell Biology

The Role of EMC during Membrane Protein Biogensis

Patrick J. Chitwood et al.

TRENDS IN CELL BIOLOGY (2019)

添加到收藏夹

Article Oncology

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

A. B. Schrock et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer

J. L. Hu et al.

MOLECULAR CANCER (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2019)

添加到收藏夹

Review Oncology

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic

T. A. Chan et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

TMEM Proteins in Cancer: A Review

Kathleen Schmit et al.

FRONTIERS IN PHARMACOLOGY (2018)

添加到收藏夹

Article Oncology

The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging

Mahul B. Amin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2017)

添加到收藏夹

Review Oncology

Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

J. M. Pitt et al.

ANNALS OF ONCOLOGY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Classification and characterization of microsatellite instability across 18 cancer types

Ronald J. Hanse et al.

NATURE MEDICINE (2016)

添加到收藏夹

Review Oncology

The biology and function of fibroblasts in cancer

Raghu Kalluri

NATURE REVIEWS CANCER (2016)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

Bo Li et al.

GENOME BIOLOGY (2016)

添加到收藏夹

Article Oncology

Overexpression of TMEM158 contributes to ovarian carcinogenesis

Zhongping Cheng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Oncology

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Berna C. Oezdemir et al.

CANCER CELL (2014)

添加到收藏夹

Review Oncology

Disease-free survival as an end-point in the treatment of solid tumours - Perspectives from clinical trials and clinical practice

Andrew G. Robinson et al.

EUROPEAN JOURNAL OF CANCER (2014)

添加到收藏夹

Editorial Material Genetics & Heredity

Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas

Larsson Omberg et al.

NATURE GENETICS (2013)

添加到收藏夹

Editorial Material Genetics & Heredity

The Cancer Genome Atlas Pan-Cancer analysis project

John N. Weinstein et al.

NATURE GENETICS (2013)

添加到收藏夹

Article Respiratory System

TMEM158 and FBLP1 as novel marker genes of cisplatin sensitivity in non-small cell lung cancer cells

Ahmed El Sayed Mohammed et al.

EXPERIMENTAL LUNG RESEARCH (2012)

添加到收藏夹

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

CELL (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Overcoming the challenges of membrane protein crystallography

Elisabeth P. Carpenter et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)

添加到收藏夹

Article Oncology

Target genes of the WNT/β-catenin pathway in Wilms tumors

B Zirn et al.

GENES CHROMOSOMES & CANCER (2006)

添加到收藏夹

Article Oncology

RIS1, a gene with trinucleotide repeats, is a target in the mutator pathway of colorectal carcinogenesis

Daniel Iglesias et al.

CANCER GENETICS AND CYTOGENETICS (2006)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas

J Silva et al.

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2006)

添加到收藏夹

Review Oncology

A twist for survival and cancer progression

A Puisieux et al.

BRITISH JOURNAL OF CANCER (2006)

添加到收藏夹

Article Oncology

Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence

M Barradas et al.

EXPERIMENTAL CELL RESEARCH (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.